Go Deep
SUSMED,Inc.
SUSMED,Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,806 | -15.1 | 1.43 | 0.00 | 208.25 |
SUSMED,Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 175,160,000.0 | 230,742,000.0 | 45,441,000.0 | 45,868,000.0 |
| Net Profit | 222,413,000.0 | -332,424,000.0 | -152,023,000.0 | -120,657,000.0 |
| EPS | — | -19.7 | — | -7.2 |
SUSMED,Inc. Revenue & Profit: Last 5 Years
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | 497,211,000.0 | — | 342,577,000.0 | 530,654,000.0 | 316,873,000.0 |
| Net Profit | -382,691,000.0 | — | -357,415,000.0 | -50,749,000.0 | -233,483,000.0 |
| EPS | -22.7 | -17.8 | -21.4 | -3.1 | — |
SUSMED,Inc. Balance Sheet
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Total Assets | 4,218,107,000.0 | — | 4,932,086,000.0 | 5,101,124,000.0 | 4,943,723,000.0 |
| Total Liabilities | 147,944,000.0 | — | 327,789,000.0 | 230,327,000.0 | 93,339,000.0 |
| Total Equity | 4,070,163,000.0 | — | 4,604,297,000.0 | 4,870,797,000.0 | 4,850,384,000.0 |
Owes vs Owns
SUSMED,Inc. owed ¥0.04 for every ¥1 it owned in Jun 2026, up from ¥0.02 in Jun 2022.
| Period | Jun 2026 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Owes vs Owns | 0.04× | 0.07× | 0.05× | 0.02× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
SUSMED,Inc. Assets & Liabilities Breakdown (JPY millions)
What it owns — Jun 2026
Cash & short-term investments 87.7%Receivables 6.5%Intangible assets 2.1%Other assets 3.6%
How it's funded — Jun 2026
Payables 1.9%Other liabilities 1.6%Shareholders' equity 96.5%
| Line Item | Jun 2026 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3,698.3 | 4,846.9 | 5,048.8 | 4,904.1 |
| Receivables | 273.8 | 10.4 | 10.9 | 9.6 |
| Inventory | 0.1 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 6.4 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 88.7 | 8.5 | 7.6 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 150.9 | 66.3 | 33.8 | 30.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 81.3 | 67.1 | 82.3 | 70.5 |
| Other liabilities | 66.7 | 260.7 | 148.0 | 22.9 |
| Shareholders' equity | 4,070.2 | 4,604.3 | 4,870.8 | 4,850.4 |
| Net tangible assets | 3,981.5 | 4,595.8 | 4,863.2 | 4,850.4 |
SUSMED,Inc. Cash Flow
| Line Item | Jun 2026 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Operating Activities | -474,454,000.0 | -230,762,000.0 | 100,591,000.0 | -165,283,000.0 |
| Investing Activities | -228,130,000.0 | -8,528,000.0 | -18,189,000.0 | -20,362,000.0 |
| Financing Activities | 2,747,000.0 | 37,372,000.0 | 62,362,000.0 | 3,463,075,000.0 |